Impact BioMedical (IBO) news
Recent news
DSS, Inc. announces Form F-4 filing in connection with Impact Biomedical’s proposed business combination with Zoar Limited
DSS, Inc. has announced the filing of a Form F-4 registration statement with the U.S. Securities and Exchange Commission (SEC) in connection with Impact Biomedical's proposed business combination . The filing is part of the regulatory process required to facilitate the merger, which is expected to…
AInvest Wire · Sep 16, 2026Corrected - Impact Biomedical Inc (NYSE: IBO): 1 for 12.62 reverse stock split to pursue completion of merger with Zoar
Impact BioMedical Inc. (NYSE American: IBO) has announced a 1-for-12.62 reverse stock split of its issued and outstanding common stock, effective at 12:01 a.m. Eastern Time on September 23, 2026. The move is intended to support the company’s ongoing efforts to complete a proposed merger with Zoar…
AInvest Wire · Sep 15, 2026Impact Biomedical Inc (NYSE American: IBO): 1 for 12.62 reverse stock split to pursue completion of merger with Zoar
AInvest Wire · Sep 11, 2026ImportantEU Court of Justice rules on WIBOR-linked mortgages
AInvest Wire · Feb 12, 2026HK dollar HIBOR falls most since 2008 after HKMA intervention
AInvest Wire · May 7, 2025Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.